生物活性硬骨素Elisa試劑盒-Bioactive Sclerostin ELISA Kit代理/參數(shù)/廠家-ELISA試劑盒-艾美捷科技有限公司

PRODUCT CENTER

ELISA試劑盒

產(chǎn)品中心

當前位置：首頁 > 產(chǎn)品中心 > 免疫學產(chǎn)品 > ELISA試劑盒

購買方式: 90%產(chǎn)品中國有現(xiàn)貨庫存。銀行轉賬、電匯、支票、現(xiàn)金，在線支付寶及網(wǎng)銀支付，或直接與我們電話聯(lián)系400-6800-868

背景資料: Sclerostin is a 22.5 kDa secreted glycoprotein that functions as a potent inhibitor of Wnt signaling. It acts by binding to the Wnt-coreceptor LRP5/6 thus inhibiting bone formation by regulating osteoblast function and promoting osteoblast apoptosis. The Sclerostin protein consists of two flexible N- and C-terminal arms and a cystine-knot with three loops, whereas the second loop binds to the LRP5/6 complex. Sclerostin is classically considered to be a monomeric protein, but data from Hernandez and colleagues (Hernandez et al., 2014) postulate that circulating sclerostin has a dimeric configuration. In addition, it is not yet well documented if also Sclerostin fragments circulate, but the comparison of different Sclerostin ELISAs suggest that fragments exist as well (Dallas et al., 2013).

產(chǎn)品描述: Method Sandwich ELISA, HRP/TMB, 12×8-well detachable strips Sample type Serum, EDTA plasma and citrate plasma Sample volume 20 μl / well Assay time 2 h / 1 h / 30 min Sensitivity 1.9 pmol/l (= 42.7 pg/ml) Standard range 0 – 320 pmol/l (= 0 – 7 200 pg/ml) Conversion factor 1 pmol/l = 22.5 pg/ml (MW: 22.5 kDa) Precision In-between-run (n=7): ≤5 % CV Within-run (n=3): ≤ 1 % CV Specificity Endogenous and recombinant bioactive Sclerostin.

其他: Biomedica Immunoassay(bmgrp)公司成立于1988年, 總部位于奧地利維也納，主要致力于研究、開發(fā)和生產(chǎn)基于ELISA方法用于臨床前研究相關標記物檢測的工具。迄今為止Biomedica Immunoassay公司在心血管檢測及骨代謝檢測領域開發(fā)了一系列特色ELISA檢測試劑盒，Biomedica Immunoassay的生產(chǎn)過程符合GMP/GLP指南，并符合ISO 9001:2015管理體系，有CE認證。Biomedica Immunoassay的產(chǎn)品根據(jù)FDA， EMEA和ICH指南進行驗證，并具有驗證報告。